These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9298256)

  • 1. Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver.
    Sielaff TD; Nyberg SL; Rollins MD; Hu MY; Amiot B; Lee A; Wu FJ; Hu WS; Cerra FB
    Cell Biol Toxicol; 1997 Jul; 13(4-5):357-64. PubMed ID: 9298256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a hybrid bioartificial liver using primary hepatocytes entrapped in a basement membrane matrix.
    Nagaki M; Miki K; Kim YI; Ishiyama H; Hirahara I; Takahashi H; Sugiyama A; Muto Y; Moriwaki H
    Dig Dis Sci; 2001 May; 46(5):1046-56. PubMed ID: 11341648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary culture of rat hepatocytes entrapped in cylindrical collagen gels: an in vitro system with application to the bioartificial liver. Rat hepatocytes cultured in cylindrical collagen gels.
    Nyberg SL; Shatford RA; Payne WD; Hu WS; Cerra FB
    Cytotechnology; 1992; 10(3):205-15. PubMed ID: 1369236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hollow fiber bioartificial liver utilizing collagen-entrapped porcine hepatocyte spheroids.
    Wu FJ; Friend JR; Lazar A; Mann HJ; Remmel RP; Cerra FB; Hu WS
    Biotechnol Bioeng; 1996 Oct; 52(1):34-44. PubMed ID: 18629850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoprotection of xenocytes in a hollow fiber bioartificial liver.
    Nyberg SL; Platt JL; Shirabe K; Payne WD; Hu WS; Cerra FB
    ASAIO J; 1992; 38(3):M463-7. PubMed ID: 1457903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte function in a hollow fiber bioreactor: a potential bioartificial liver.
    Shatford RA; Nyberg SL; Meier SJ; White JG; Payne WD; Hu WS; Cerra FB
    J Surg Res; 1992 Dec; 53(6):549-57. PubMed ID: 1494286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hepatocyte growth factor on viability and biotransformation functions of hepatocytes in gel entrapped and monolayer culture.
    Hu MY; Cipolle M; Sielaff T; Lovdahl MJ; Mann HJ; Remmel RP; Cerra FB
    Crit Care Med; 1995 Jul; 23(7):1237-42. PubMed ID: 7600833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial liver support devices for fulminant liver failure.
    Sechser A; Osorio J; Freise C; Osorio RW
    Clin Liver Dis; 2001 May; 5(2):415-30. PubMed ID: 11385970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive biochemical effects of a bioartificial liver support system (BALSS) in a porcine fulminant hepatic failure (FHF) model.
    Sheil AG; Sun J; Mears DC; Waring M; Woodman K; Johnston B; Horvat M; Watson J; Koutalistras N; Wang L
    Int J Artif Organs; 1998 Jan; 21(1):43-8. PubMed ID: 9554825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions.
    Nyberg SL; Shirabe K; Peshwa MV; Sielaff TD; Crotty PL; Mann HJ; Remmel RP; Payne WD; Hu WS; Cerra FB
    Cell Transplant; 1993; 2(6):441-52. PubMed ID: 8167929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival, proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a reliable bioartificial liver.
    Joly A; Desjardins JF; Fremond B; Desille M; Campion JP; Malledant Y; Lebreton Y; Semana G; Edwards-Levy F; Levy MC; Clement B
    Transplantation; 1997 Mar; 63(6):795-803. PubMed ID: 9089217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates.
    Flendrig LM; la Soe JW; Jörning GG; Steenbeek A; Karlsen OT; Bovée WM; Ladiges NC; te Velde AA; Chamuleau RA
    J Hepatol; 1997 Jun; 26(6):1379-92. PubMed ID: 9210627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen consumption in a hollow fiber bioartificial liver--revisited.
    Patzer JF
    Artif Organs; 2004 Jan; 28(1):83-98. PubMed ID: 14720293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a hollow fiber bioartificial liver device.
    Abu-Absi SF; Seth G; Narayanan RA; Groehler K; Lai P; Anderson ML; Sielaff T; Hu WS
    Artif Organs; 2005 May; 29(5):419-22. PubMed ID: 15854219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a hepatocyte-entrapment hollow fiber bioreactor: a potential bioartificial liver.
    Nyberg SL; Shatford RA; Peshwa MV; White JG; Cerra FB; Hu WS
    Biotechnol Bioeng; 1993 Jan; 41(2):194-203. PubMed ID: 18609538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term liver cell cultures in bioreactors and possible application for liver support.
    Gerlach JC
    Cell Biol Toxicol; 1997 Jul; 13(4-5):349-55. PubMed ID: 9298255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cultivation of primary porcine hepatocytes in an OXY-HFB for use as a bioartificial liver device.
    Jasmund I; Langsch A; Simmoteit R; Bader A
    Biotechnol Prog; 2002; 18(4):839-46. PubMed ID: 12153319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel bioartificial liver with culture of porcine hepatocyte aggregates under simulated microgravity.
    Hochleitner B; Hengster P; Duo L; Bucher H; Klima G; Margreiter R
    Artif Organs; 2005 Jan; 29(1):58-66. PubMed ID: 15644085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support.
    Ambrosino G; Varotto S; Stefano Basso SM; Galavotri D; Cecchetto A; Carraro P; Naso A; De Silvestro G; Plebani M; Giron G; Abatangelo G; Donato D; Cestrone A; Marrelli L; Trombetta M; Lorenzelli V; Picardi A; Colantoni A; Van Thiel D; Ricordi C; D'Amico FD
    ASAIO J; 2002; 48(6):592-7. PubMed ID: 12455768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-based therapy of acute liver failure: the extracorporeal bioartificial liver.
    Frémond B; Joly A; Desille M; Desjardins JF; Campion JP; Clément B
    Cell Biol Toxicol; 1996 Dec; 12(4-6):325-9. PubMed ID: 9034628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.